Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension

NCT00171054 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Valsartan 320 mg
DRUG: Amlodipine 10 mg
DRUG: Hydrochlorothiazide

Sponsor

Novartis